Genfit
Manufacturing · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Parc Eurasanté 885 Avenue Eugène Avinée,...Phone Number
+33 320164000Website
www.genfit.comRevenue
$28.6 MillionStock Symbol
GNFTIndustry
About Genfit
Genfit Org Chart
Is Genfit your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Genfit recently announced quarterly report
Funding: Get notified immidiatlly once Genfit has new funding data
Check if Genfit has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Genfit
Click to see if Genfit had a recent Job posting/layoffs
Check out if Genfit is spiking on competitors!
Product Launch: Get notified when Genfit launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Genfit, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Genfit
Find 3 more new buyers
Company Profile Activity
Activity Insights
Genfit is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Genfit is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Genfit.
Genfit financials insights
Gather financial insights about Genfit, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Share Placement
$15.5M
Share Placement
$5.4M
Share Placement
$22.7M
Share Placement
$36.6M
Share Placement
$48.2M
Debt
$194.5M
Stock Offering
$155.4M
Debt
$13.3M
Debt
$200M
Genfit Tech Stack
A closer look at the technologies used by Genfit
Most Recent Scoops
Genfit News & Media
GENFIT to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
GENFIT to Join CAC Mid 60 and SBF 120 Indices on Euronext ParisGENFIT to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Lille (France), Cambridge (Massachusetts, United States), September 10, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that management will participate in the upcoming H.C. Wainwright 28th Annual Global Investment Conference.GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology
GENFIT highlights the long-term commercial opportunity associated with NIS4® and next-generation NIS2+®GENFIT to Host Virtual KOL Event Focused on MASH Diagnostics on September 9, 2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 3, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that it will host a virtual key opinion leader (KOL) event on Wednesday, September 9, 2026 at 10:00 AM ET. The event will highlight the evolving landscape of diagnostic testing for Metabolic dysfunction-Associated SteatoHepatitis (MASH) an
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Genfit
Genfit, founded in 1999 and headquartered in Loos Hauts-de-France, is a bio-pharmaceutical company that develops therapeutic, and diagnostic solutions to meet needs in the field of metabolic and inflammatory disease.... Read More